Effect of Visceral and Parietal Peritoneum Suturation on Postoperative Vital Signs
NCT ID: NCT02581293
Last Updated: 2015-10-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1
132 participants
INTERVENTIONAL
2015-03-31
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Extraperitoneal and Intraperitoneal Cesarean Technique
NCT02760290
Assessment of Single and Double Layer Suturation of Lower Segment Uterine Incision by USG After C/S
NCT03676907
The Effect of Abdominal Binder Use on Postpartum Pain, Bleeding, and Breastfeeding Success in Cesarean Delivery Women
NCT04965779
The Effect of Saline Irrigation in the Peritoneal Cavity at Cesarean Delivery
NCT01716091
The Effect of Amniotic Membrane Application on Post-Cesarean Wound Healing and Cosmetic Outcomes
NCT06770946
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Group1: Only visceral peritoneum will be closed
Group 2: Only parietal peritoneum will be closed
Group 3: Both of them will be closed
Group 4: None of them will be closed
During the postoperative period all patients will undergo vital sign screening including urine output, blood pressure measurement, pulse rate and VAS score will be determined at post operative 6th hour and 24th hour.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Only visceral peritoneum will be closed
Group1: Only visceral peritoneum will be closed
Group 1: Only visceral peritoneum will be closed
Only parietal peritoneum will be closed
Group 2: Only parietal peritoneum will be closed
Group 2 : Only parietal peritoneum will be closed
Both of them will be closed
Group 3: Both of them will be closed
Group 3 : Both of them will be closed
None of them will be closed
Group 4: None of them will be closed
Group 4: None of them will be closed
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 1: Only visceral peritoneum will be closed
Group 2 : Only parietal peritoneum will be closed
Group 3 : Both of them will be closed
Group 4: None of them will be closed
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Pregnant with Obstetric complications
* Pregnant with two or more previous c-sections
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zeynep Kamil Maternity and Pediatric Research and Training Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MERYEM Kurek EKEN
M.D
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Enis Özkaya, Assoc. Prof.
Role: PRINCIPAL_INVESTIGATOR
Zeynep Kamil Education and Research Hospital Obstetric and Gynecology Department
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meryem Kurek EKEN
Istanbul, Üsküdar, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
31/2015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.